Remus Pharmaceuticals Ltd KYS Report: Ownership & Insights | Research 360

15:59 Dec 12

Remus Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

753.65

+27.70 (+3.82%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Remus Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Dec 12

753.65

+27.70 (+3.82%)

0/100 Not Eligible

Quality

22/100 Expensive Valuation

Valuation

39/100 Technically Neutral

Technical

SWOT

Strength

3

Weakness

1

Opportunity

0

Threat

0

888.10

Market Cap (Cr)

30.55

PE Ratio

3.47

Price to Book Ratio

59.22

RSI

4.68 %

Net Profit Margin

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password